Dr. de Quadros and Hotez featured in Vaccine special supplement!

Earlier this week 13 pharmaceutical companies*, together with several government and nongovernmental organizations**, pledged to find solutions to eliminate or control 10 neglected tropical diseases (NTDs) by the year 2020. At an event in London, pharmaceutical companies committed to invest in research and development (R&D) to find new treatments for NTDs along with increasing donations of existing drugs.
Albert B Sabin is probably best known for his work and research on the polio virus. During World War II he worked on and developed vaccines for encephalitis (sleeping sickness), sand-fly fever and dengue fever as well. It is his work into dengue fever during this time that is now having possible implications for vaccine development today — 60 years later.

The World Health Organization (WHO) and the Public Library of Science (PLoS) are launching a new initiative to support the latest WHO World Health Report by encouraging authors to submit articles that substantiate the WHO's message, that research is essential for better

In an op-ed published Friday, Sabin president Peter Hotez, M.D., Ph.D., and his Baylor College of Medicine colleague, William Brinkley, Ph.D., applaud the dramatic gains Texas institutions have made to become leaders among the global scientific community. They cite the routinely high ranking of public and private Texas universities as well as a voter approved amendment to start the Cancer Prevention and Research Institute of Texas (CPRIT).

Gift giving can become tiresome. There is the shopping, and the wondering if your online shipment will arrive in time, or worse, actually going to a mall. There is the wrapping, but remember, not before you fly. Then, of course, there is the deflated feeling that it really doesn’t matter.

Last week leaders in global health and tropical medicine convened in Philadelphia to talk about the latest scientific advances in their field as well as the current status of efforts to control tropica

Financing research and development (R&D) for neglected tropical disease (NTDs) is a big challenge. The problem? Market failure.

The Global Network, the Sabin product development partnership (PDP) and Dr. Peter Hotez, Sabin president, were featured in a great piece on Forbes today.

In two articles published today, Dr. Peter Hotez speaks out about the burden of neglected tropical diseases (NTDs) on people living in poverty in the United States.

Pages